Demant A/S

DEMANT

DK0060738599

Medical Equipment, Supplies & Distribution

Market Closed - Nasdaq Copenhagen Other stock markets 16:20:00 02/07/2024 BST			5-day change	1st Jan Change
298 ^DKK	-1.26%		-4.79%	+0.68%

06-26	Demant Flags Delay in Completion of Communications Business' Strategic Review	MT
05-29	UK’s Competition Regulator Closes Cochlear-Demant Deal	MT

Demant A/S Appoints Anja Madsen to Board of Directors

March 10, 2020 at 04:14 pm

Demant A/S at its annual general meeting held on 10 March 2020 announced that Anja Madsen was elected new member of the Board of Directors.

Latest news about Demant A/S

Demant Flags Delay in Completion of Communications Business' Strategic Review	06-26	MT
UK’s Competition Regulator Closes Cochlear-Demant Deal	05-29	MT
Denmark's Demant Completes Sale of Cochlear Implants Business	05-21	MT
Cochlear Limited acquired Oticon Medical A/s from Demant A/S.	05-20	CI
DEMANT : Q1 sales miss; organic growth guidance unchanged	05-06
Transcript : Demant A/S, Q1 2024 Interim Management Statement Call, May 06, 2024	05-06
Hearing Healthcare Company Demant Affirms FY24 Outlook	05-06	MT
Demant A/S Provides Earnings Guidance for the Year 2024	05-06	CI
Denmark's Demant Finalizes Capital Reduction	04-08	MT
Competition Regulator Clears Cochlear’s Acquisition of Oticon Medical’s Cochlear Implant Business	04-04	MT
Demant Seeks Acquisitions	03-12	CI
Transcript : Demant A/S - Analyst/Investor Day	03-12
Nordic Stocks Closed Down Wednesday; Electrolux Series a Posted Biggest Loss	02-28	DJ
Anja Madsen Announces Not to Stand for Re-Election to the Board of Directors of Demant A/S	02-07	CI
Nordic Shares Rose Tuesday; Demant Climbed Highest	02-06	DJ
DEMANT : In-line Q4; markets cheer the promising takeaways for 2024	02-06
Global markets live: BP, Palantir, Infineon, Toyota, UBS...	02-06
Transcript : Demant A/S, 2023 Earnings Call, Feb 06, 2024	02-06
US Futures Mixed, European Stocks Rise as Investors Parse More Fedspeak	02-06	DJ
Tranche Update on Demant A/S's Equity Buyback Plan announced on March 5, 2021.	02-06	CI
Demant A/S Reports Earnings Results for the Full Year Ended December 31, 2023	02-06	CI
Demant Forecasts Up to 8% Organic Revenue Growth in FY24	02-06	MT
Demant to Explore Strategic Options for Communications Business Amid Weak Market Conditions	02-05	MT
Demant A/S Provides Earnings Guidance for the Year 2024	02-05	CI
Demant A/S Promotes Peter Pudselykke as Head of Investor Relations Effective 1 March 2024	01-03	CI

Demant A/S is the world's 2nd leading producer of audio products. Net sales (excluding activities held for sale) break down by family of products as follows: - tailor-made hearing aids (44.7%): hearing aid and audiphones sold under the Oticon, Bernafon, Philips and Sonic brands; - hearing care products (40.5%): sold in clinics under the brands Audika, HearingLife, Hidden Hearing and Acústica Médica; - diagnostic products (1116%): audiometers sold under the brands Maico, Interacoustics, amplivox, gsi, MedRx and audioscan; - business communication solutions (3.7%). Net sales (excluding activities held for sale) are distributed geographically as follows: Denmark (1.2%), France (9.9%), Europe (29.7%), the United States (34.1%), North America (7%), Asia (10.4%), Pacific (4.9%) and other (2.8%).

Sector

Medical Equipment, Supplies & Distribution

Calendar

13/08/2024 - Q2 2024 Earnings Release

Related indices

STOXX EUROPE 600 (EUR)

More about the company

Income Statement Evolution

More financial data

Analysis / Opinion

DEMANT : Q1 sales miss; organic growth guidance unchanged

May 06, 2024 at 04:18 pm

More Strategies

Ratings for Demant A/S

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

298 DKK

Average target price

336.7 DKK

Spread / Average Target

+12.98%

Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

	1st Jan change	Capi.
DEMANT A/S	+0.68%	9.45B
STRAUMANN HOLDING AG	-15.89%	19.88B
COCHLEAR LIMITED	+5.73%	14.04B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD.	-25.94%	1.89B
EMBLA MEDICAL HF.	+7.47%	1.82B
ANGELALIGN TECHNOLOGY INC.	+8.75%	1.23B
MODERN DENTAL GROUP LIMITED	-1.63%	521M
ANGEL ROBOTICS CO., LTD.	0.00%	364M
DELCATH SYSTEMS, INC.	+90.14%	230M
INTEGRUM AB	+25.74%	105M

Medical Prosthetics

Demant A/S

Equities

DEMANT

DK0060738599

Medical Equipment, Supplies & Distribution

Demant A/S Appoints Anja Madsen to Board of Directors

Latest news about Demant A/S

Chart Demant A/S

Company Profile

Income Statement Evolution

Analysis / Opinion

Ratings for Demant A/S

Analysts' Consensus

EPS Revisions

Quarterly earnings - Rate of surprise

Sector Medical Prosthetics